{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:17:35Z","timestamp":1790457455318,"version":"4.1.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773438"],"award-info":[{"award-number":["81773438"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Orphanet J Rare Dis"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>This study explores and discusses the possible factors affecting the positive predictive value (PPV) of non-invasive prenatal screening (NIPS) for the detection of fetal copy number variants (CNVs) in pregnant women.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>NIPS was performed for 50,972 pregnant women and 212 cases were suspected as fetal CNVs. Post additional genetic counseling for these women, 96 underwent invasive prenatal diagnosis (amniocentesis), following which they received chromosomal microarray analysis (CMA). We analyzed the PPV of NIPS for the detection of fetal CNVs and the possible interference factors that could affect the PPV.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Among the 96 pregnant women that received prenatal diagnosis by CMA, 37 cases were confirmed to be true positive for fetal CNVs with a PPV of 38.5%. There was no significant difference between the women with different NIPS indications. Five cases were reported as the false positive and false negative of fetal CNVs and the differences were mainly reflected in the inconsistency of chromosome fragments. Depending on the sizes of the CNVs, the PPVs were 48.7% for CNVs\u2009&lt;\u20093\u00a0Mb, 41.4% for CNVs falling within 3\u2009~\u20095\u00a0Mb, 42.9% for the CNVs falling within 5\u2009~\u200910\u00a0Mb, and 14.3% for CNVs\u2009&gt;\u200910\u00a0Mb. Based on the chromosomal locations of CNVs, the PPV(4.8%) of the chromosomes of group C(including chromosomes 6\u2009~\u200912), was lower than that of the other groups (41.2%\u2009~\u200966.7%) (<jats:italic>p<\/jats:italic>\u2009=\u20090.021). However, there were no significant differences in the CNV characteristics, fetal fractions, unique reads, and the Z-scores between these groups.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>NIPS with a low-coverage sequencing depth has a certain effect on detection of fetal CNVs with the PPV of 38.5%. Chromosomal locations of CNVs may be the main factor that influences its effect. This study can contribute to an increased accuracy in genetic counseling and in predicting NIPS results that are positive for fetal CNVs.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s13023-022-02406-6","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:03:06Z","timestamp":1657278186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Clinical evaluation of non-invasive prenatal screening for the detection of fetal genome-wide copy number variants"],"prefix":"10.1186","volume":"17","author":[{"given":"Wenli","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengying","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7796-7314","authenticated-orcid":false,"given":"Bin","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"23","key":"2406_CR1","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1056\/NEJMoa1203382","volume":"367","author":"RJ Wapner","year":"2012","unstructured":"Wapner RJ, Cl Martin B, Levy BCB, Eng CM, Zachary JM, Savage M, Platt LD, Saltzman D, Grobman WA, et al. Chromosomal microarray versus karyotyping for prenatal diagnosis. N Engl J Med. 2012;367(23):2175\u201384.","journal-title":"N Engl J Med"},{"issue":"6","key":"2406_CR2","first-page":"578","volume":"371","author":"N Vrachnis","year":"2014","unstructured":"Vrachnis N, Vlachadis N, Creatsas G. DNA sequencing versus standard prenatal aneuploidy screening. N Engl J Med. 2014;371(6):578.","journal-title":"N Engl J Med"},{"issue":"4","key":"2406_CR3","first-page":"e361","volume":"211","author":"TJ Garite","year":"2014","unstructured":"Garite TJ, Porreco RP, Maurel K, Marusiak B, Network OCR, Ehrich M, Van Den Boom D, Deciu C, Bombard A. Noninvasive prenatal screening for fetal trisomies 21, 18, 13 and the common sex chromosome aneuploidies from maternal blood using massively parallel genomic sequencing of DNA. Am J Obstet Gynecol. 2014;211(4):e361\u2013e312.","journal-title":"Am J Obstet Gynecol"},{"issue":"27","key":"2406_CR4","doi-asserted-by":"publisher","first-page":"e7114","DOI":"10.1097\/MD.0000000000007114","volume":"96","author":"B Yu","year":"2017","unstructured":"Yu B, Lu BY, Zhang B, Zhang XQ, Chen YP, Zhou Q, Jiang J, Wang HY. Overall evaluation of the clinical value of prenatal screening for fetal-free DNA in maternal blood. Med (Baltimore). 2017;96(27):e7114.","journal-title":"Med (Baltimore)"},{"issue":"1","key":"2406_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/uog.13361","volume":"44","author":"H Yao","year":"2014","unstructured":"Yao H, Jiang F, Hu H, Gao Y, Zhu Z, Zhang H, Wang Y, Guo Y, Liu L, Yuan Y, et al. Detection of fetal sex chromosome aneuploidy by massively parallel sequencing of maternal plasma DNA: initial experience in a Chinese hospital. Ultrasound Obstet Gynecol. 2014;44(1):17\u201324.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"5","key":"2406_CR6","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1002\/pd.4338","volume":"34","author":"J Hooks","year":"2014","unstructured":"Hooks J, Wolfberg AJ, Wang ET, Struble CA, Zahn J, Juneau K, Mohseni M, Huang S, Bogard P, Song K, et al. Non-invasive risk assessment of fetal sex chromosome aneuploidy through directed analysis and incorporation of fetal fraction. Prenat Diagn. 2014;34(5):496\u20139.","journal-title":"Prenat Diagn"},{"key":"2406_CR7","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1038\/s41436-019-0467-4","volume":"21","author":"D Liang","year":"2019","unstructured":"Liang D, Cram DS, Tan H, Linpeng S, Liu Y, Sun H, Zhang Y, Tian F, Zhu H, Xu M, et al. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes. Genet Med. 2019;21:1998\u20132006.","journal-title":"Genet Med"},{"issue":"2","key":"2406_CR8","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/cge.13098","volume":"93","author":"K Martin","year":"2018","unstructured":"Martin K, Iyengar S, Kalyan A, Lan C, Simon AL, Stosic M, Kobara K, Ravi H, Truong T, Ryan A, et al. Clinical experience with a single-nucleotide polymorphism-based non-invasive prenatal test for five clinically significant microdeletions. Clin Genet. 2018;93(2):293\u2013300.","journal-title":"Clin Genet"},{"issue":"1","key":"2406_CR9","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/uog.14911","volume":"47","author":"R Li","year":"2016","unstructured":"Li R, Wan J, Zhang Y, Fu F, Ou Y, Jing X, Li J, Li D, Liao C. Detection of fetal copy number variants by non-invasive prenatal testing for common aneuploidies. Ultrasound Obstet Gynecol. 2016;47(1):53\u20137.","journal-title":"Ultrasound Obstet Gynecol"},{"issue":"12","key":"2406_CR10","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1038\/gim.2017.54","volume":"19","author":"M Han","year":"2017","unstructured":"Han M, Li Z, Wang W, Huang S, Lu Y, Gao Z, Wang L, Kang D, Li L, Liu Y, et al. A quantitative cSMART assay for noninvasive prenatal screening of autosomal recessive nonsyndromic hearing loss caused by GJB2 and SLC26A4 mutations. Genet Med. 2017;19(12):1309\u201316.","journal-title":"Genet Med"},{"issue":"11","key":"2406_CR11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1038\/gim.2014.207","volume":"17","author":"Y Xu","year":"2015","unstructured":"Xu Y, Li X, Ge HJ, Xiao B, Zhang YY, Ying XM, Pan XY, Wang L, Xie WW, Ni L, et al. Haplotype-based approach for noninvasive prenatal tests of Duchenne muscular dystrophy using cell-free fetal DNA in maternal plasma. Genet Med. 2015;17(11):889\u201396.","journal-title":"Genet Med"},{"issue":"1","key":"2406_CR12","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1373\/clinchem.2014.229328","volume":"61","author":"W Lv","year":"2015","unstructured":"Lv W, Wei X, Guo R, Liu Q, Zheng Y, Chang J, Bai T, Li H, Zhang J, Song Z, et al. Noninvasive prenatal testing for Wilson disease by use of circulating single-molecule amplification and resequencing technology (cSMART). Clin Chem. 2015;61(1):172\u201381.","journal-title":"Clin Chem"},{"issue":"7","key":"2406_CR13","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.1373\/clinchem.2011.180794","volume":"58","author":"TJ Jensen","year":"2012","unstructured":"Jensen TJ, Dzakula Z, Deciu C, Van Den Boom D, Ehrich M. Detection of microdeletion 22q11.2 in a fetus by next-generation sequencing of maternal plasma. Clin Chem. 2012;58(7):1148\u201351.","journal-title":"Clin Chem"},{"issue":"3","key":"2406_CR14","doi-asserted-by":"publisher","first-page":"332e1","DOI":"10.1016\/j.ajog.2014.11.041","volume":"212","author":"RJ Wapner","year":"2015","unstructured":"Wapner RJ, Babiarz JE, Levy B, Stosic M, Zimmermann B, Sigurjonsson S, Wayham N, Ryan A, Banjevic M, Lacroute P, et al. Expanding the scope of noninvasive prenatal testing: detection of fetal microdeletion syndromes. Am J Obstet Gynecol. 2015;212(3):332e1\u20139.","journal-title":"Am J Obstet Gynecol"},{"issue":"1","key":"2406_CR15","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s40246-019-0250-2","volume":"13","author":"Y Chen","year":"2019","unstructured":"Chen Y, Yu Q, Mao X, Lei W, He M, Lu W. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions\/microduplications in a cohort of 42,910 single pregnancies with different clinical features. Hum Genomics. 2019;13(1):60.","journal-title":"Hum Genomics"},{"issue":"1","key":"2406_CR16","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s40246-019-0198-2","volume":"13","author":"H Hu","year":"2019","unstructured":"Hu H, Wang L, Wu J, Zhou P, Fu J, Sun J, Cai W, Liu H, Yang Y. Noninvasive prenatal testing for chromosome aneuploidies and subchromosomal microdeletions_microduplications in a cohort of 8141 single pregnancies. Hum Genomics. 2019;13(1):14.","journal-title":"Hum Genomics"},{"key":"2406_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1016\/j.ejogrb.2020.11.026","volume":"256","author":"X Ye","year":"2021","unstructured":"Ye X, Lin S, Song X, Tan M, Li J, Wang J, Yan H, Zhang H, Li S, Chen D, et al. Identification of copy number variants by NGS-based NIPT at low sequencing depth. Eur J Obstet Gynecol Reprod Biol. 2021;256:297\u2013301.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"2406_CR18","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1002\/pd.6002","volume":"41","author":"P Shi","year":"2021","unstructured":"Shi P, Wang Y, Liang H, Hou Y, Chen D, Zhao G, Dai P, Xia Y, Feng Y, Cram DS, et al. The potential of expanded noninvasive prenatal screening for detection of microdeletion and microduplication syndromes. Prenat Diagn. 2021;41:1332\u201342.","journal-title":"Prenat Diagn"},{"key":"2406_CR19","first-page":"1","volume":"32","author":"B Yu","year":"2018","unstructured":"Yu B, Li H, Chen YP, Zhang B, Xue Y, He Q, Zhou Q, Cai Z, Wang T. Clinical evaluation of NIPS for women at advanced maternal age: a multicenter retrospective study. J Matern Fetal Neonatal Med. 2018;32:1\u20136.","journal-title":"J Matern Fetal Neonatal Med"},{"key":"2406_CR20","first-page":"2145701","volume":"2020","author":"J Xu","year":"2020","unstructured":"Xu J, Xue Y, Wang J, Zhou Q, Zhang B, Yu B, Wang T. The necessity of prenatal diagnosis by CMA for the women with NIPS-positive results. Int J Genomics. 2020;2020:2145701.","journal-title":"Int J Genomics"},{"issue":"14","key":"2406_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.21037\/atm.2019.06.63","volume":"7","author":"Ye Shi","year":"2019","unstructured":"Shi Ye, Jun Ma, Ying X, Wang Jing Yu, Bin WT. The assessment of combined karyotype analysis and chromosomal microarray in pregnant women of advanced maternal age: a multicenter study. Ann Transl Med. 2019;7(14):18.","journal-title":"Ann Transl Med"},{"issue":"2","key":"2406_CR22","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1038\/s41436-019-0686-8","volume":"22","author":"ER Riggs","year":"2020","unstructured":"Riggs ER, Andersen EF, Cherry AM, Kantarci S, Kearney H, Patel A, Raca G, Ritter DI, South ST, Thorland EC, et al. Technical standards for the interpretation and reporting of constitutional copy-number variants: a joint consensus recommendation of the American college of medical genetics and genomics (ACMG) and the clinical genome resource (ClinGen). Genet Med. 2020;22(2):245\u201357.","journal-title":"Genet Med"},{"key":"2406_CR23","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3389\/fgene.2018.00509","volume":"9","author":"B Yu","year":"2018","unstructured":"Yu B, Long W, Yang Y, Wang Y, Jiang L, Cai Z, Wang H. Newborn screening and molecular profile of congenital hypothyroidism in a Chinese population. Front Genet. 2018;9:509.","journal-title":"Front Genet"},{"issue":"1","key":"2406_CR24","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/s40246-021-00332-5","volume":"15","author":"J Yang","year":"2021","unstructured":"Yang J, Wu J, Peng H, Hou Y, Guo F, Wang D, Ouyang H, Wang Y, Yin A. Performances of NIPT for copy number variations at different sequencing depths using the semiconductor sequencing platform. Hum Genomics. 2021;15(1):41.","journal-title":"Hum Genomics"},{"issue":"1","key":"2406_CR25","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1186\/s12920-021-00955-6","volume":"14","author":"Y Ge","year":"2021","unstructured":"Ge Y, Li J, Zhuang J, Zhang J, Huang Y, Tan M, Li W, Chen J, Zhou Y. Expanded noninvasive prenatal testing for fetal aneuploidy and copy number variations and parental willingness for invasive diagnosis in a cohort of 18,516 cases. BMC Med Genomics. 2021;14(1):106.","journal-title":"BMC Med Genomics"},{"issue":"1","key":"2406_CR26","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1186\/s12884-021-03918-y","volume":"21","author":"J Zhang","year":"2021","unstructured":"Zhang J, Tang X, Hu J, He G, Wang J, Zhu Y, Zhu B. Investigation on combined copy number variation sequencing and cytogenetic karyotyping for prenatal diagnosis. BMC Pregnancy Childbirth. 2021;21(1):496.","journal-title":"BMC Pregnancy Childbirth"},{"issue":"8","key":"2406_CR27","first-page":"569","volume":"10","author":"M Hyblova","year":"2020","unstructured":"Hyblova M, Harsanyova M, Nikulenkov-Grochova D, Kadlecova J, Kucharik M, Budis J, Minarik G. Validation of copy number variants detection from pregnant plasma using low-pass whole-genome sequencing in noninvasive prenatal testing-like settings. Diagn (Basel, Switzerland). 2020;10(8):569.","journal-title":"Diagn (Basel, Switzerland)"},{"issue":"6","key":"2406_CR28","doi-asserted-by":"crossref","first-page":"e674","DOI":"10.1002\/mgg3.674","volume":"7","author":"D Yu","year":"2019","unstructured":"Yu D, Zhang K, Han M, Pan W, Chen Y, Wang Y, Jiao H, Duan L, Zhu Q, Song X, et al. Noninvasive prenatal testing for fetal subchromosomal copy number variations and chromosomal aneuploidy by low-pass whole-genome sequencing. Mol Gen Genomic Med. 2019;7(6):e674.","journal-title":"Mol Gen Genomic Med"}],"container-title":["Orphanet Journal of Rare Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02406-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13023-022-02406-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13023-022-02406-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T10:33:57Z","timestamp":1700822037000},"score":1,"resource":{"primary":{"URL":"https:\/\/ojrd.biomedcentral.com\/articles\/10.1186\/s13023-022-02406-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["2406"],"URL":"https:\/\/doi.org\/10.1186\/s13023-022-02406-6","relation":{},"ISSN":["1750-1172"],"issn-type":[{"value":"1750-1172","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"13 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study design and protocol were reviewed and approved by the ethics committee of Changzhou Maternal and Child Health Care Hospital (No. 201501). All pregnant women received genetic counseling and signed a written consent before the test.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"253"}}